Carregant...
Edoxaban in patients with atrial fibrillation
Edoxaban, a direct factor Xa inhibitor, was extensively studied in the prevention and treatment of venous thromboembolism and in patients with nonvalvular atrial fibrillation (AF). The aim of this review is to focus specifically on the efficacy and safety profile of edoxaban in patients with AF from...
Guardat en:
| Publicat a: | Ther Adv Cardiovasc Dis |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5942795/ https://ncbi.nlm.nih.gov/pubmed/26680560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944715622130 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|